ASX - By Stock
|
AHF |
Re:
Ann: Sale and Leaseback of Brucknell North Farm
|
|
Hdavid92
|
18 |
7.3K |
10 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
18
|
7.3K
|
10
|
|
ASX - By Stock
|
AHF |
Re:
Ann: AHF confirms application for FDA Approval
|
|
Hdavid92
|
28 |
12K |
1 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
28
|
12K
|
1
|
|
ASX - By Stock
|
AHF |
Re:
Ann: AHF confirms application for FDA Approval
|
|
Hdavid92
|
28 |
12K |
5 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
28
|
12K
|
5
|
|
ASX - By Stock
|
AHF |
Re:
Ann: AHF confirms application for FDA Approval
|
|
Hdavid92
|
28 |
12K |
4 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
28
|
12K
|
4
|
|
ASX - By Stock
|
AHF |
Re:
Ann: AHF confirms application for FDA Approval
|
|
Hdavid92
|
28 |
12K |
8 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
28
|
12K
|
8
|
|
ASX - By Stock
|
NXS |
Re:
Ann: 2021 Annual Report
|
|
Hdavid92
|
17 |
8.1K |
5 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
17
|
8.1K
|
5
|
|
ASX - By Stock
|
NXS |
Re:
Ann: 2021 Annual Report
|
|
Hdavid92
|
17 |
8.1K |
3 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
17
|
8.1K
|
3
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Hdavid92
|
932 |
1.1M |
1 |
21/03/22 |
21/03/22 |
Charts
|
932
|
1.1M
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
4 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
1.8K
|
593K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
5 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
1.8K
|
593K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
4 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
1.8K
|
593K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
1.8K
|
593K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Next Science SPP Offer Opens
|
|
Hdavid92
|
6 |
3.9K |
0 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
6
|
3.9K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
1 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
SPZ |
Re:
PBNs capped by UK Govt
|
|
Hdavid92
|
3 |
1.3K |
0 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Hdavid92
|
16 |
5.7K |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
16
|
5.7K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation
|
|
Hdavid92
|
16 |
5.7K |
9 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
16
|
5.7K
|
9
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Trading Halt
|
|
Hdavid92
|
2 |
1.0K |
1 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Investor Presentation
|
|
Hdavid92
|
47 |
20K |
8 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
47
|
20K
|
8
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo H1 FY22 Results Investor Briefing
|
|
Hdavid92
|
13 |
5.5K |
0 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
13
|
5.5K
|
0
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation - Q4 FY21
|
|
Hdavid92
|
10 |
4.7K |
4 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
10
|
4.7K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
3 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
3 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
3 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
3
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Investor Presentation - Q4 FY21
|
|
Hdavid92
|
10 |
4.7K |
4 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
10
|
4.7K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
6 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
4 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
4
|
|
ASX - By Stock
|
AMP |
Re:
Ann: AMP Full Year Results & Appendix 4E
|
|
Hdavid92
|
156 |
33K |
1 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
156
|
33K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives approval for its COVID-19 antigen test in NZ
|
|
Hdavid92
|
14 |
7.9K |
4 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
14
|
7.9K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
1 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
1 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
3 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Hdavid92
|
2.4K |
776K |
2 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
2.4K
|
776K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
6 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
1.8K
|
593K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Hdavid92
|
2.4K |
776K |
5 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
2.4K
|
776K
|
5
|
|
ASX - By Stock
|
NXS |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
6 |
1.7K |
1 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
6
|
1.7K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
0 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
1.8K
|
593K
|
0
|
|
Charts
|
NXS |
Re:
Charts NXS
|
|
Hdavid92
|
932 |
1.1M |
2 |
28/01/22 |
28/01/22 |
Charts
|
932
|
1.1M
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Hdavid92
|
1.8K |
593K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Atomo receives approval for its COVID-19 antigen test in NZ
|
|
Hdavid92
|
14 |
7.9K |
7 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
14
|
7.9K
|
7
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
webinar
|
|
Hdavid92
|
3 |
1.0K |
6 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
3
|
1.0K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
4 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
4 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
4
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
0 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
0 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Appendix 4C - 31 December 2021
|
|
Hdavid92
|
26 |
7.0K |
8 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
26
|
7.0K
|
8
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Investor Briefing - Q2 FY22 Results
|
|
Hdavid92
|
5 |
2.6K |
7 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
5
|
2.6K
|
7
|
|